Profile data is unavailable for this security.
About the company
Molecular Pharmacology (USA) Limited (Molecular USA) is an Australia-based development Stage company together with its subsidiary, Molecular Pharmacology Pty. Ltd. (MPLA) is in the business of developing and commercializing an analgesic and anti-inflammatory molecule known as Tripeptofen. The Company’s over-the-counter anti-pain and anti-inflammatory products sold for the treatment of acute localized pain are based on non-steroidal anti-inflammatory drugs (NSAIDs). The licensed products include all products in all dosage forms, formulations, line extensions and package configurations using production method of metallo-polypeptide analgesic and anti-inflammatory activity as an active ingredient marketed by MPLA or its affiliates under the trade name Tripeptofen. The Company and Molecular Pharmacology Pty. Ltd. have no manufacturing facilities.
- Revenue in USD (TTM)0.00
- Net income in USD-105.18k
- Incorporated2002
- Employees0.00
- LocationMolecular Pharmacology (USA) LtdDrug Discovery Research Ctr284 Oxford StLEEDERVILLE 6007AustraliaAUS
- Phone+61 89443-3011
- Fax+61 89443-3866
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meso Numismatics Inc | 2.41m | -9.81m | 449.78k | 1.00 | -- | -- | -- | 0.1866 | -0.7886 | -0.7886 | 0.1936 | -1.74 | 0.4398 | -- | 65.37 | -- | -179.09 | -192.08 | -- | -- | 69.53 | 60.24 | -407.21 | -821.49 | -- | -0.1103 | -- | -- | 57.49 | 116.97 | -76.03 | -- | 149.35 | -- |
| Hanyuan Biotech International Inc | 10.65m | 3.14m | 539.39k | -- | 0.0294 | 0.0064 | 0.1481 | 0.0506 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Better Therapeutics Inc | 0.00 | -31.57m | 555.96k | 54.00 | -- | -- | -- | -- | -1.16 | -1.16 | 0.00 | -0.2449 | 0.00 | -- | -- | 0.00 | -162.15 | -- | -378.28 | -- | -- | -- | -- | -- | -- | -15.18 | 3.27 | -- | -- | -- | 1.43 | -- | -- | -- |
| Molecular Pharmacology (USA) Ltd | 0.00 | -105.18k | 599.73k | 0.00 | -- | -- | -- | -- | -0.0009 | -0.0009 | 0.00 | -0.0188 | 0.00 | -- | -- | -- | -976.60 | -1,219.29 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 44.29 | -- | -- | -- |
| Health Advance Inc | -100.00bn | -100.00bn | 604.33k | 3.00 | -- | 0.1537 | -- | -- | -- | -- | -- | 0.0212 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0356 | -- | 100.00 | -- | -21.75 | -- | -- | -- |
| Emo Capital Corp | -100.00bn | -100.00bn | 639.85k | 0.00 | -- | -- | -- | -- | -- | -- | -- | -0.0017 | -- | -- | -- | -- | -- | -7,495.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -138.44 | -- | -- | -- |
| NovAccess Global Inc | 0.00 | -1.74m | 669.04k | 1.00 | -- | -- | -- | -- | -0.1193 | -0.1193 | 0.00 | -0.2246 | 0.00 | -- | -- | 0.00 | -1,836.30 | -2,185.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -177.93 | -- | -- | -- |
| Bellerophon Therapeutics Inc | 5.64m | -9.25m | 697.26k | 18.00 | -- | 0.1873 | -- | 0.1236 | -0.8353 | -0.8353 | 0.5054 | 0.3044 | 0.6414 | -- | -- | 313,333.30 | -105.23 | -55.57 | -165.94 | -77.33 | -- | -- | -164.06 | -- | -- | -- | 0.00 | -- | -- | -- | -11.69 | -- | -- | -- |
| GlobeStar Therapeutics Corp | 0.00 | -1.98m | 697.75k | -- | -- | -- | -- | -- | -0.0023 | -0.0023 | 0.00 | -0.0015 | 0.00 | -- | -- | -- | -38,103.72 | -4,657.88 | -- | -- | -- | -7,790.20 | -- | -2,834,410.00 | -- | -21.00 | -- | -- | -- | -- | -31.01 | -- | -- | -- |
| International Stem Cell Corp | 7.83m | -327.00k | 720.40k | 29.00 | -- | -- | -- | 0.092 | -0.0409 | -0.0409 | 0.9785 | 0.0045 | 1.46 | 2.53 | 11.87 | 270,069.00 | -5.81 | -29.22 | -68.13 | -73.82 | 58.58 | 59.49 | -3.97 | -21.01 | 0.4672 | -6.06 | 0.9898 | -- | -4.78 | -6.82 | 60.42 | -- | -34.45 | -- |
| Capstone Holding Corp | 0.00 | -358.00k | 728.95k | 2.00 | -- | -- | -- | -- | -6.58 | -38.12 | 0.00 | -60.70 | 0.00 | -- | -- | -- | -113.46 | 141.94 | -199.60 | 173.06 | -- | -- | -- | -- | -- | -2.92 | -- | -- | -- | -- | 52.46 | -- | -- | -- |
| Acorda Therapeutics Inc | 115.66m | -263.43m | 751.47k | 102.00 | -- | -- | -- | 0.0065 | -212.10 | -212.10 | 93.13 | -149.56 | 0.5068 | 1.14 | 12.59 | 1,133,961.00 | -115.42 | -26.62 | -266.35 | -31.97 | 86.38 | 78.22 | -227.75 | -111.91 | 0.1533 | -0.692 | 33.57 | -- | -0.7869 | -24.24 | -283.60 | -- | -62.13 | -- |
| Evelo Biosciences Inc | 0.00 | -82.35m | 768.60k | 66.00 | -- | -- | -- | -- | -13.34 | -13.34 | 0.00 | -1.42 | 0.00 | -- | -- | 0.00 | -153.98 | -97.80 | -408.83 | -112.80 | -- | -- | -- | -- | -- | -15.30 | 4.69 | -- | -- | -- | 6.26 | -- | -18.61 | -- |
